Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

NCT05966480 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

SLE

Interventions

DRUG: Envudeucitinib
DRUG: Placebo

Sponsor

Alumis Inc